The integrity of the biomedical literature is essential to ensuring that all who seek advances in basic and clinical science have a robust, high-caliber resource from which to draw. It is for this express reason that across the publishing industry, biomedical publishers large and small and editors' groups (eg, International Committee of Medical Journal Editors, World Association of Medical Editors, and Committee on Publication Ethics) have taken concerted action to confront the rising incidence of intentional manipulation of the scholarly literature through the use of ghostwriters and the failure to accurately report the roles and contributions of authors, sponsors, and others who are assigned credit for involvement in the research effort. Such action has, in large part, focused on the establishment of editorial policies pertaining to authorship criteria and financial disclosures. That Bosch et al had ample numbers of editorial policies drawn up by biomedical journals to include in a cross-sectional study is a testament to the widespread adoption of these policies and their importance to publishers of medical and scientific research.
Nancarrow CM. Editorial Policies to Ensure Honesty and Transparency Comment on “Ghostwriting Policies in High-Impact Biomedical Journals: A Cross-Sectional Study”. JAMA Intern Med. 2013;173(10):921-922. doi:10.1001/jamainternmed.2013.746